ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR/ARHP Annual Meeting 2018

Abstract Number: 1249

Contraception Compliance in Patients with Rheumatological Diseases on Disease Modifying Antirheumatic and Cytotoxic Drugs

Sara Naji Rad1, Paris Pacheco2, Luis Calvo2, Htet Htet Maung2, Wajiha Illyas2 and Prachi Anand3, 1Internal Medicine, Nassau University Medical Center, East meadow, NY, 2Internal Medicine, Nassau University Medical Center, East Meadow, NY, 3Chief of Rheumatology, Nassau University Medical Center, East Meadow, NY

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR/ARHP Annual Meeting 2018

Keywords: immunosuppressants, pregnancy and rheumatic disease

Session Information

Date: Monday, October 22, 2018

Title: Measures and Measurement of Healthcare Quality Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Women of child bearing age with autoimmune diseases are often prescribed teratogenic medications as Methotrexate, Mycophenolate Mofetil, Leflunomide and Cyclophosphamide. Contraceptive compliance in this group of patients has been shown to be low. Patients are required to use reliable methods of birth control to prevent undesirable consequences. Our goal was to improve documentation of variables which help physicians to assess contraception compliance in this group of patients and minimize the deviation from standard of care.

Methods: This study had two retrospective arms, pre and post-implementation of immunosuppressive section to rheumatology clinic note. Subjects are females (50 cases in each arm) aged 21-50 y/o on immunosuppressive medications who are sextually active. Females with hysterectomy, tubal ligation and prisoners were excluded. Variables subjected to review included plan to conceive, contraception use, contraception method, gynecology referral. We applied Chi-squared test to analyze the data.

Results: Documentation of four variables mentioned above was compared between two 50-patient groups (pre-intervention vs post-intervention). There was statistically significant improvement in documentation of all four variables following the intervention as follows: plan to conceive (84% vs 36%)(p=0.000001), contraception used (90% vs 54%)(p=0.00006), type of contraception (76% vs 50%)(p=0.007), gynecology referral (84% vs 38%)(p=0.000002).

Conclusion: Identification of variables which represent patients’ compliance is essential and should be addressed in each patient visit. In this study we improved documentation of variables which could help clinician in early recognizing patients who do not follow the guidelines for contraception to consider them for close monitoring or switch to non-teratogenic medications. In this study in light of poor documentation in the first arm we were unable to compare contraception compliance of patients pre and post intervention.


Disclosure: S. Naji Rad, None; P. Pacheco, None; L. Calvo, None; H. H. Maung, None; W. Illyas, None; P. Anand, None.

To cite this abstract in AMA style:

Naji Rad S, Pacheco P, Calvo L, Maung HH, Illyas W, Anand P. Contraception Compliance in Patients with Rheumatological Diseases on Disease Modifying Antirheumatic and Cytotoxic Drugs [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/contraception-compliance-in-patients-with-rheumatological-diseases-on-disease-modifying-antirheumatic-and-cytotoxic-drugs/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/contraception-compliance-in-patients-with-rheumatological-diseases-on-disease-modifying-antirheumatic-and-cytotoxic-drugs/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology